Document ID: chunk:federal_register_of_legislation:F2020L00493:reg:9:p2
Version: federal_register_of_legislation:F2020L00493
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6625–9501

and:
(a)          smoking commenced at least five years before the clinical onset of malignant neoplasm of the liver; and
(b)          where smoking has ceased, the clinical onset of malignant neoplasm of the liver has occurred within 20 years of cessation;
            Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(12)      having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the liver at least five years before the clinical onset of malignant neoplasm of the liver;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(13)      being treated with systemic immunosuppressive therapy for solid organ, stem cell or bone marrow transplantation before the clinical onset of malignant neoplasm of the liver;
(14)      being exposed to high levels of dietary aflatoxins, on more days than not, for a period of at least five years within the 30 years before the clinical onset of malignant neoplasm of the liver;
            Note: being exposed to high levels of dietary aflatoxins is defined in the Schedule 1 - Dictionary.
(15)      inhaling a cumulative dose of at least 1 250 ppm-years of gaseous vinyl chloride at least five years before the clinical onset of malignant neoplasm of the liver;
Note: ppm-years is defined in the Schedule 1 - Dictionary.
(16)      inhaling gaseous vinyl chloride for a cumulative period of at least 5 000 hours while working in the production or processing of vinyl chloride monomer or polyvinyl chloride, at least five years before the clinical onset of malignant neoplasm of the liver;
(17)      inhaling respirable asbestos fibres in an enclosed space:
(a)           for a cumulative period of at least 1 000 hours before the clinical onset of malignant neoplasm of the liver; and
(b)           at the time material containing respirable asbestos fibres was being applied, removed, dislodged, cut or drilled; and
(c)           where the first inhalation of respirable asbestos fibres commenced at least five years before the clinical onset of malignant neoplasm of the liver;
(18)      inhaling respirable asbestos fibres in an open environment:
(a)           for a cumulative period of at least 3 000 hours before the clinical onset of malignant neoplasm of the liver; and
(b)           at the time material containing respirable asbestos fibres was being applied, removed, dislodged, cut or drilled; and
(c)           where the first inhalation of respirable asbestos fibres commenced at least five years before the clinical onset of malignant neoplasm of the liver;
(19)      an inability to undertake any physical activity greater than three METs for at least ten years within the 15 years before the clinical onset of malignant neoplasm of the liver;
Note: MET is defined in the Schedule 1